2 dec 2025
Fi Europe 2025
Dongsheng Biotech/ ACE Ingredients

Dongsheng Biotech/ ACE Ingredients

Exhibitor at Fi Europe 2025 stand 71N44 & stand 71N44, Health Ingredients

About us

Dongsheng Biotech (Taixing) Co., Ltd. has been committed to the field of biological fermentation technology for more than 20 years, a high-tech enterprise integrating with research and development (R&D), manufacture and sales.

Dongsheng Biotech (Taixing) Co., Ltd. is located in the garden-styled digital production base of Huangqiao Economic Development Zone. The company established and officially put into production in September 2021, which covering an area of 165 acres of farmland, with a total investment of 95 million U$D. Taixing Dongsheng Bio-Tech Co., Ltd. processes 8 sets of 60 tons fermentation tanks and 10 sets of 130 tons fermentation tanks with a three-stage fermentation process that can achieve an annual production capacity of 400 tons of pure transglutaminase and 2000 tons of curdlan.

In 2020, Dongsheng Bio-Tech Co., Ltd. has invested additional 85 million U$D to build a state of the art production base for manufacturing enzymatic preparations and other functional and synergic food ingredients solution.


Specs about this supplier

Sales markets Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe
Affiliated categories: Other Enzymes |Other Functional Ingredient Mixtures |Transglutaminase More

Products featured at Fi Europe 2025

Dongsheng Biotech/ ACE Ingredients

Event information

Fi Europe 2025

2 - 4 December 2025 Paris Expo Porte de Versailles Visit us at stand 71N44